Jolavi 5mg Tablet contains Midodrine 5mg, an alpha-1 adrenergic agonist primarily indicated for the treatment of symptomatic orthostatic hypotension. Midodrine exerts its pharmacological effect by stimulating alpha-1 adrenergic receptors on the vascular smooth muscle, leading to vasoconstriction and an increase in peripheral vascular resistance, which subsequently elevates blood pressure. This mechanism helps alleviate symptoms such as dizziness, lightheadedness, and syncope associated with low blood pressure upon standing. Jolavi is typically administered orally, with dosage tailored to the patient’s clinical response and tolerance. It is contraindicated in patients with severe organic heart disease, acute renal disease, urinary retention, pheochromocytoma, or thyrotoxicosis. Caution is advised in patients with hypertension, bradycardia, or those taking other medications that may affect blood pressure. Common adverse effects include piloerection, pruritus, urinary retention, and supine hypertension. Regular monitoring of blood pressure, both supine and standing, is recommended to minimize the risk of adverse events. Jolavi should be used under strict medical supervision, ensuring appropriate dose adjustments and evaluation of therapeutic efficacy. It is essential to inform patients about the importance of adherence and the potential side effects associated with Midodrine therapy.